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ABSTRACT (max 250 words) 
 
Introduction: Behavioural support aids smoking cessation in pregnancy. However, it remains unclear 
which component behaviour change techniques (BCTs) contribute to effectiveness, or the extent to 
which these are applied in practice. This study aimed to examine: i) which BCTs were included in 
effective behavioural support interventions for pregnant smokers, and ii) the prevalence of use of these 
BCTs by the English Stop Smoking Services (SSSs).  
Methods: From a Cochrane review of smoking cessation behavioural support in pregnancy, seven 
interventions were identified as effective in that they increased the odds of cessation by at least 50% 
and differences between intervention and control conditions were statistically significant. BCTs in 
each intervention were identified using an established taxonomy of BCTs. Thirteen treatment manuals 
from SSSs were coded for inclusion of BCTs.  
Results: Thirty-seven BCTs were identified across trials of behavioural support for pregnant smokers, 
with an average of eight BCTs, and a range of six to 34 BCTs, per intervention. Eleven BCTs were 
present in at least two effective interventions [e.g. facilitate goal setting (n=6), advise on social support 
(n=2), action planning (n=5), provide rewards contingent on successfully stopping smoking (n=4)]. 
Only 15.4% of treatment manuals from SSSs contained all eleven BCTs; 53.8% contained at least six 
of them.  
Conclusions: Whilst BCTs associated with effective interventions can be identified from 
systematically reviewed literature, English SSSs appear to use only a limited proportion of these in 
practice.  
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INTRODUCTION 
Smoking while pregnant is a major preventable cause of infant mortality and morbidity (Cnattingius, 
2004). Promoting smoking cessation in pregnancy is therefore a public health priority (Dept. of Health, 
2000). There are several types of interventions available for helping pregnant smokers to quit, 
including medications and face-to-face or telephone behavioural support. Smoking cessation 
behavioural support involves advising on and facilitating activities aimed at helping the quit attempt to 
succeed. There is good evidence from published randomized controlled trials (RCTs) that behavioral 
support can aid cessation in pregnant smokers (Lumley, Chamberlain, Dowsell et al. 2009), whereas to 
date there is not good evidence for the efficacy of nicotine replacement therapy (Silagy, Lancaster, 
Stead et al. 2007) and other stop-smoking medications are contra-indicated during pregnancy (NICE, 
2010). In the UK, an increasing number of English NHS Stop Smoking Services (SSSs) offer free, 
specialist behavioural support tailored to the needs of specific population groups such as pregnant 
smokers. Of the 21,839 pregnant women setting a quit date with a SSS in 2010/2011, 27% were 
abstinent at 4-week follow up, confirmed by CO verification (NHS, 2011). 
 
However despite their overall effectiveness, behaviour change interventions, such as behavioural 
support for smoking cessation, are typically complex in that they consist of multiple, potentially 
interacting behaviour change techniques (BCTs). BCTs are the replicable components of an 
intervention designed to alter or redirect causal processes regulating behaviour (Michie, Hyder, West 
et al. 2011). As a result of the complexity of these interventions, it is not clear which specific 
component BCTs have been included in existing effective RCTs of behavioural support for smoking 
cessation in pregnancy, and therefore which BCTs should form the basis for practice. It also remains 
unknown the extent to which BCTs forming behavioural support interventions in effective trials are 
subsequently employed in practice by the NHS SSSs.   
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A reliable coding-based method for specifying the content of smoking cessation behavioural support 
interventions in terms of their component BCTs has recently been developed (Michie et al. 2011). This 
is in the form of a taxonomy of 43 conceptually distinct smoking cessation BCTs that are described 
using consistent terminology and detailed definitions. BCTs in the taxonomy are organized 
hierarchically, categorised by four behaviour change functions: 1) ‘Boost motivation,’ 2) ‘Maximize 
self-regulatory capacity and skills,’ 3) ‘Promote adjuvant activities,’ and 4) ‘General aspects of the 
role/interaction.’ (Michie, et al. 2011). This taxonomy has been reliably applied as a coding framework 
to specify BCTs comprising published descriptions of effective generic individual and group 
behavioural support interventions, and to examine the extent to which these identified evidence-based 
BCTs featured in treatment manuals from the NHS SSSs (Michie, Churchill & West, 2010). It has also 
supported the identification of a sub-set of BCTs featured in generic NHS SSSs behavioural support 
treatment manuals that were reliably associated with improved 4-week CO-validated quit outcomes in 
the NHS SSSs (West, Walia, Michie et al, 2011). To our knowledge, the functional components of 
effective behavioural support interventions in specialist population groups such as pregnant smokers 
have not yet been specified in this way.  
 
The present study aims to apply the taxonomy of smoking cessation BCTs to: (i) examine which BCTs 
were used in effective RCTs of behavioural support interventions for smoking cessation in pregnancy, 
and how these compare to previously identified evidence-based BCTs for generic behavioural support; 
and (ii) to assess the extent to which treatment manuals from specialist pregnancy NHS SSSs include 
BCTs identified as evidence-based for pregnancy-specific behavioural support. 
 
METHODS 
This study followed the methods of Michie, Churchill & West (2010) and was conducted in two 
stages. 
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i) Stage 1: Specifying evidence-based BCTs for smoking cessation behavioural support in 
pregnancy 
Component BCTs included in effective behavioural support interventions were specified using a 
published taxonomy of smoking cessation BCTs (Michie et al. 2011) as a coding framework. Effective 
interventions were identified from the Cochrane review, ‘Interventions for promoting smoking 
cessation in pregnancy’ (Lumley, Chamberlain, Dowswell et al. 2009). An intervention was classified 
as effective if it increased the probability of cessation by at least 50% (OR≥1.50) and the differences 
between the intervention and control group were statistically significant (p<0.05) (Michie, Churchill & 
West 2010). Lead authors of interventions identified as effective were contacted twice with a request 
for their trial protocol or any additional available materials detailing the intervention’s content; where 
no protocol was available or no response received, coding was conducted using the intervention 
description in the corresponding published trial report.  
 
Coding was conducted by assigning a BCT label from the taxonomy where appropriate to sections of 
the trial report or manual that described the intervention treatment condition. Data on the frequency of 
BCT use across trials was extracted throughout. A BCT was classified as ‘evidence-based’ if it 
featured in at least two of the effective interventions included in the review (criteria from Michie, 
Churchill & West 2010). The sub-set of BCTs identified as evidence-based for smoking cessation in 
pregnancy was then compared with the sub-set of BCTs identified as evidence-based for generic 
individual behavioural support (n=14 BCTs) (Michie, Churchill & West, 2010), and also to a second, 
distinct sub-set of 14 BCTs found to be associated with improved 4-week quit outcomes in NHS SSSs 
(West, Walia, Michie et al., 2010).  
 
ii) Stage 2: Examine prevalence of use of evidence-based BCTs by the SSSs 
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The content of SSSs treatment manuals for smoking cessation behavioural support in pregnancy were 
coded for the presence of the sub-set of evidence-based BCTs identified in stage 1. Service Managers 
from all English NHS primary care trusts (PCTs) (n=152) were contacted on up to three occasions with 
a request for any available service treatment manuals or guidance documents outlining content 
recommendations and specifications for delivering behavioural support to pregnant smokers. Two 
researchers independently assessed the documents received to determine whether they constituted a 
treatment manual, presently defined as a formal, written plan specifying procedures to be followed in 
providing a specific treatment or support for smoking cessation to pregnant smokers. Manuals were 
coded for component BCTs following the same content analysis coding procedures as stage 1. The 
proportion of SSSs treatment manuals that contained all identified evidence-based BCTs for 
pregnancy-specific support, and that which contained at least six BCTs (i.e. more than half), was 
noted.  
 
For both published trial descriptions/protocols and SSSs treatment manuals, a second independent 
coder coded a sub-set of materials (33%). Inter-rater reliability for identifying the same BCTs from 
intervention descriptions was assessed using percentage agreement. Where one coder failed to identify 
a BCT or a different BCT was identified, disagreement was registered. Discrepancies were resolved 
through discussion or through consultation with a behaviour change expert (SM).  
 
RESULTS 
i) Stage 1: Evidence-based BCTs for smoking cessation behavioural support in pregnancy 
The Cochrane review of interventions for promoting smoking cessation in pregnancy included 56 
randomized controlled trials (RCTs). Seven interventions, all RCTs of one-to-one behavioural support, 
were classified as effective according to our study criteria (Heil, Higgings, Bernstein et al., 2008; 
Polanska, Hanke, Sobala et al., 2004; Higgins, Heil, Solomon et al., 2004; Hjalmarson, Hahn & 
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Savenberg 1991; Donatelle, Prows, Champeau et al., 2009; Walsh, Redman, Brinsmead et al., 1997; 
Lawrence, Aveyard, Cheng et al., 2003). Three studies were conducted in the USA, three in Europe 
(UK, Poland, Sweden) and one in Australia. A trial manual and additional information on intervention 
content was received for only one trial (Walsh et al., 1997).  
 
Inter-rater coding reliability was high (93% agreement), with all discrepancies resolved through 
discussion. Thirty-seven of the original 43 BCTs (86%) in the taxonomy were identified at least once 
across effective trials of behavioural support for pregnant smokers (Table 1). No new BCTs not 
already included in the taxonomy were identified. The number of BCTs identified per effective 
behavioural support intervention condition ranged from six to 34, with an average of eight BCTs per 
intervention (SD 9.9). Eleven BCTs (29.7%) were identified in at least two interventions, therefore 
meeting our effectiveness criteria (Table 2). Of these, three (27.2%) served the behaviour change 
function ‘boost motivation;’ four (36.4%) served the function ‘maximising self-regulatory capacity and 
skills;’ one (9.1%) served ‘promoting adjuvant activities;’ and three (27.2%) pertained to ‘general 
aspects of the role/interaction’ (Table 1). 
 
Of the 11 identified evidence-based BCTs for behavioural support in pregnancy, nine (81.8%) were 
also featured in the sub-set of evidence-based BCTs for generic one-to-one behavioural support 
(Michie, Churchill, & West, 2010). Only two BCTs in the sub-set of evidence-based BCTs for 
smoking cessation in pregnancy were not included in the original generic set. These were: ‘Advise 
on/facilitate use of social support’ and ‘Provide rewards contingent on successfully stopping smoking.’ 
Of the 11 evidence-based BCTs identified for pregnancy-specific support, four (28.6%) were also 
included in the second sub-set of BCTs identified as associated with improved 4-week quit rates in the 
NHS SSSs (West Walia, Michie et al., 2011). These were: ‘Provide rewards contingent on successfully 
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stopping smoking’; ‘Measure CO’; ‘Advise on/facilitate use of social support’; and ‘Facilitate relapse 
prevention and coping’ (Table 2). 
 
ii) Stage 2: Prevalence of use of evidence-based BCTs by the SSSs 
Of the 152 SSS managers contacted, 128 (84%) responded. Of these, 113 (88%) reported having a 
service dedicated to providing behavioural support to pregnant smokers. Of these, only 32 (25%) 
reported having treatment manuals. Documents were received from 23 (72%) services, of which 13 
(57%) were classified as manuals and contained sufficient detail for BCT identification.  
 
Inter-rater reliability for coding BCTs was high (88%), with all discrepancies easily resolved through 
discussion. Manuals contained a range of two to 11 evidence-based BCTs per manual, with an average 
of seven (SD 2.79) BCTs per manual, (Table 3). Two manuals contained all 11 evidence-based BCTs 
(15.4%), and seven manuals (53.8%) contained at least six (i.e. more than half) of the identified 
evidence-based BCTs (Table 3).  
 
DISCUSSION 
Eleven evidence-based behaviour change techniques (BCTs) for smoking cessation behavioural 
support in pregnancy were identified from published descriptions of the content of multiple effective 
behavioural support interventions for pregnant smokers. This sub-set of evidence-based BCTs is 
consistent with previous studies highlighting the evidence-base for specific smoking cessation BCTs 
(Michie, Churchill & West 2010; West, Walia, Michie et al., 2011); four BCTs from this sub-set have 
also featured in a sub-set of fourteen BCTs demonstrated to be reliably associated with improved four-
week quit rates in the NHS SSSs (West, Walia, Michie et al., 2010). Furthermore only two BCTs 
identified as evidence-based for smoking cessation in pregnancy were not also identified in more than 
two effective generic behavioural support RCTs: ‘provide rewards contingent on successfully stopping 
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smoking’ and ‘advise on/facilitate use of social support.’ A review of the use of incentives in smoking 
cessation interventions with pregnant smokers has found that rewards and incentives have been 
incorporated into some worksite and community-based smoking cessation interventions with pregnant 
smokers, particularly those of lower socio-economic status, to achieve successful quit outcomes 
(Donatelle, Udson, Dobie et al., 2004). Similarly, providing positive social support within behavioural 
support, such as by giving compliments and expressing willingness to help with daily activities, has 
been found to be associated with improved quit outcomes in pregnancy (McBride, Grothaus, Pirie et 
al., 1998). There is also evidence suggesting that pregnant women are more likely to notice their 
partner’s social support during a quit attempt than are non-pregnant women (Haug, Fugelli, Aaro et al., 
1994).  The emergence of BCTs uniquely evidence-based for pregnancy-specific behavioural support 
interventions underlines the need to tailor support provided to the unique needs of this population 
group. Design of future trial and practice interventions targeting pregnant smokers should emphasise 
BCTs addressing social support and/or providing rewards or incentives contingent on smoking 
cessation. 
 
The sub-set of eleven identified evidence-based BCTs for smoking cessation in pregnancy included at 
least one BCT addressing each of the four behaviour change functions outlined by the taxonomy. 
Behaviour change functions reflect the mechanisms by which BCTs work to support smoking 
cessation, for example by boosting motivation or facilitating self-regulation. The four behaviour 
change functions embedded in the structure of taxonomy are consistent with a wider theory of 
motivation developed in relation to smoking cessation, PRIME theory (West, 2009). By 
systematically identifying and labeling component BCTs in interventions it is possible to examine and 
clearly describe behavioural support interventions by their key active ingredients and the 
corresponding mechanisms of action, and link these to overarching theoretical frameworks.  
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Despite a large proportion of SSSs reporting that they provided specialist pregnancy cessation services, 
we found that only a very small proportion had specific treatment manuals. Current use of evidence-
based BCTs by the NHS SSSs appears to be limited. Although most of the existing SSS treatment 
manuals contained more than half of the eleven evidence-based BCTs, only two manuals contained all 
eleven. It would seem appropriate to align practice in terms of the content of treatment manuals with 
the identified evidence base.  
 
This study had several limitations. There are many factors that influence outcomes of behavioural 
support interventions other than their content, such as general communication and therapeutic 
skills, methods of delivery and setting (Davidson, Goldstein, Kaplan et al., 2003); these are rarely 
mentioned in published trials (Glasziou, Chalmers, Altman et al., 2010). Ideally the evidence-
based of BCTs would be established by examining associations between individual techniques 
and outcomes in effective and ineffective intervention. However, both the descriptions of 
intervention content and number of trials available to us were too limited to support analytic 
methods, such as meta-regression, to partial out the influence of additional influencing factors 
and analyse effectiveness by individual BCT. A second limitation is that treatment manuals rather 
than measures of actual practice were used as a basis for examining the prevalence of use of evidence-
based BCTs in SSSs. Translation of intended practice as specified in treatment manuals into actual 
practice is rarely uniform and often lacks intervention fidelity (Borrelli, Sepinwall, Bellg, et al., 2005). 
Future research should conduct process evaluations and investigate BCTs used in actual practice by 
applying the taxonomy to code audio- or video-recorded behavioural support sessions into component 
BCTs. A third limitation is the range of countries providing data as service data were from England 
only. 
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A final consideration is that although a set of 11 component BCTs were identified as evidence-based 
for behavioural support interventions in pregnancy, other BCTs from the full taxonomy may also be 
relevant, but did not feature in sufficient studies to enable identification.  This is likely given that the 
present set of evidence-based BCTs were identified from only seven trials; had additional 
effective trials been identified or examined then potentially further evidence-based BCTs may 
have been identified as relevant. Similarly, five BCTs have been previously established as 
evidence-based for generic individual-behavioural support (Michie et al. 2010) that were not 
presently identified as evidence based for smoking cessation in pregnancy. These were: ‘advise 
on stop smoking medication,’ ‘give options for additional/later support,’ ‘provide information on 
withdrawal symptoms,’ ‘assess past history of quit attempts,’ and ‘prompt commitment from the 
client.’ Yet, all of the latter techniques are likely to also be of some relevance to smoking 
cessation support in pregnancy,  despite not presently being identified as evidence-based. For 
example, numerous stop smoking medications are contraindicated in pregnancy (i.e. varenicline, 
zyban, certain forms of  oral NRT; NICE, 2010). Therefore, delivering the BCT ‘advise on stop 
smoking medications’ is likely to be relevant to stop smoking support in pregnancy despite not 
being identified as evidence-based. Also, additional BCTs may be important in their own right for 
effectively helping smokers to quit, while others, such as ‘building rapport’ and ‘eliciting client views’ 
may adopt a more adjuvant role in supporting the effective delivery of BCTs identified as evidence-
based. Practitioners delivering interventions may thus consider applying other component BCTs from 
the taxonomy in addition to those identified as evidence-based in this study. 
 
In conclusion, given the current state of evidence, the present methods represent the best available 
intial step towards systematically specifying the content of an effective behavioural support 
intervention for smoking cessation in pregnancy. These findings represent a first attempt towards 
establishing which specific BCTs to use in supporting pregnant smokers to quit. This furthers our 
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understanding of how interventions work and what mechanisms contribute to their effectiveness, in 
turn helping inform the design of future interventions. These findings also provide a first snapshot of 
the BCTs currently used by the English SSSs when delivering support to pregnant smokers trying to 
quit, and provide a basis for investigating variations in current practice. This work forms part of an 
ongoing research program conducted by the NHS Centre for Smoking Cessation and Training 
(ncsct.co.uk) that is underpinning a national training programme for Stop Smoking Practitioners.  
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TABLES 
 
Table 1. The frequency of BCTs identified in effective behavioural support interventions, grouped according to behaviour change function 
 
BCT 
Code 
BCT Label BCT definition Number of effective 
interventions (max n=7) 
Specific focus on the target behaviour (B) and maximising motivation (M) 
 
 
BM1 
 
Provide information on consequences of 
smoking and smoking cessation 
 
Give, or make more salient, information about the harm caused by smoking and the benefits of stopping; distinguish 
between the harms from smoking and nicotine; debunk myths about low tar and own-roll cigarettes and cutting down 
 
7 
BM2 Boost motivation and self efficacy Give encouragement and bolster confidence in ability to stop 1 
BM3 Provide feedback on current behaviour Give feedback arising from assessment of current self-reported or objectively monitored behaviour (e.g. expired-air CO) 
and/or progress towards becoming a permanent non-smoker 
1 
BM4 Provide rewards contingent on 
successfully stopping smoking 
Give praise or other rewards if the person has not smoked 4 
BM5 Provide normative information about 
others' behaviour and experiences 
Give information about how the smoker’s experience compares with other people’s 2 
BM6 Prompt commitment from the client 
there and then 
Encourage the smoker to affirm or reaffirm a strong commitment to start, continue or restart the quit attempt 1 
BM7 Provide rewards contingent on effort or 
progress 
Give praise or other rewards for the effort the smoker is making and if the smoker has engaged in activities such as 
correct use of medication that aid cessation 
1 
BM8 Strengthen ex-smoker identity Explain the importance of regarding smoking as something that is ‘not an option’, including the ‘not a puff’ (NAP) rule, 
encourage the smoker to re-evaluate the attraction to smoking, and construct a new identity as someone who ‘used to 
smoke’ 
1 
BM9 Identify reasons for wanting and not 
wanting to stop smoking 
Help the smoker to arrive at a clear understanding of his or her feelings about stopping smoking, why it is important to 
stop and any conflicting motivations 
1 
BM10 Explain the importance of abrupt 
cessation 
Explain why it is better to stop abruptly rather than cut down gradually if at all possible 1 
BM11 Measure CO Measure expired-air carbon monoxide concentration 6 
 
Maximising self-regulatory capacity and skill (BS) 
 
 
BS1 
 
Facilitate barrier identification and 
problem solving 
 
Help the smoker to identify general barriers (e.g. susceptibility to stress) that might make it harder to stay off cigarettes 
and develop general ways of addressing these 
 
2 
BS2 Facilitate relapse prevention and coping Help the smoker understand how lapses occur and how they lead to relapse and to develop specific strategies for 
preventing lapses or avoiding lapses turning into relapse 
3 
BS3 Facilitate action planning/develop 
treatment plan 
Work with smoker to generate a clear quit plan including preparations for the quit attempt (e.g. obtaining medication) 5 
BS4 Facilitate goal setting Help the smoker to set a quit date and goals that support the aim of remaining abstinent 6 
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BS5 Prompt review of goals Review how far the smoker has achieved the main goal of abstinence and any other goals that are supportive of it (e.g. 
putting in place plans to avoid triggers) 
1 
BS6 Prompt self-recording Help the smoker to establish a routine of recording potentially useful information (e.g. situations or times when urges 
are strong and less strong)  
0 
BS7 Advise on changing routine Advise on ways of changing daily or weekly routines to minimise exposure to smoking cues 1 
BS8 Advise on environmental restructuring Advise on ways of changing the physical environment to minimise exposure to smoking cues (e.g. removing ashtrays 
from the house) 
1 
BS9 Set graded tasks Set small achievable goals where appropriate (e.g. take one day at a time) 1 
BS10 Advise on conserving mental resources Advise on ways of minimising stress and other demands on mental resources (activities that require mental effort) 1 
BS11 Advise on avoiding social cues for 
smoking 
Give specific advice on how to avoid being exposed to social cues for smoking (e.g. explaining to friends that you have 
stopped)  
 
1 
 
Promoting adjuvant activities (A) 
 
 
A1 Advise on stop-smoking medication Explain the benefits of medication, safety, potential side effects, contra-indications, how to use them most effectively, 
and how to get them; advise on the most appropriate medication for the smoker and promote effective use 
1 
A2 Advise on/facilitate use of social support Advise on or facilitate development of social support from friends, relatives, colleagues or ‘buddies’ 2 
A3 Adopt appropriate local procedures to 
enable clients to obtain free medication 
Enact the necessary procedures to ensure that the smoker gets his/her medication easily and without charge where 
appropriate 
0 
A4 Ask about experiences of stop smoking 
medication that the smoker is using 
Assess usage, side effects and benefits experienced of medication(s) that the smoker is currently using 0 
A5 Give options for additional and later 
support  
Give information about options for additional support where these are available (e.g. websites, self-help groups, 
telephone helpline) 
1 
 
General aspects of the role/interaction (RC) 
 
RD1 Tailor interactions appropriately  Use relevant information from the client to tailor the behavioural support provided 0 
RD2 Emphasise choice Emphasise client choice within the bounds of evidence based practice  1 
RI1 Assess current and past smoking 
behaviour 
Assess amount smoked, age when started, pattern of smoking behaviour  7 
RI2 Assess current readiness and ability to 
quit 
Assess current level of motivation to stop and confidence in success 5 
RI3 Assess past history of quit attempts Assess number and duration of past quit attempts and experiences related to these, including factors that led back to 
smoking 
1 
RI4 Assess withdrawal symptoms Assess the presence and severity of nicotine withdrawal signs and symptoms 0 
RC1 Build general rapport Establish a positive, friendly and professional relationship with the smoker and foster a sense that the smoker’s 
experiences are understood 
1 
RC2 Elicit and answer questions Prompt questions from the smoker and answer clearly and accurately 1 
RC3 Explain the purpose of CO monitoring Explain to the smoker the reasons for measuring CO at different time points, e.g. before and after the quit date 0 
RC4 Explain expectations regarding 
treatment programme 
Explain to the smoker the treatment programme, what it involves, the active ingredients and what it requires of the 
smoker 
1 
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RC5 Offer/direct towards appropriate written 
materials 
Distinguish what are, and are not, appropriate written materials and offer/direct clients to these in ways that promote 
their effective use 
7 
RC6 Provide information on withdrawal 
symptoms 
Describe to smokers what are, and are not, nicotine withdrawal symptoms, how common they are, how long they 
typically last, what causes them and what can be done to alleviate them 
1 
RC7 Use reflective listening Adopt a style of interaction that involves listening carefully to the smoker and where appropriate reflecting back to the 
smoker key elements of what s/he is saying 
1 
RC8 Elicit client views Prompt the client to give views on smoking, smoking cessation and any aspects of the behavioural support programme 1 
RC9 Summarise information / confirm client 
decisions 
Provide a summary of information exchanged and establish a clear confirmation of decisions made and commitments 
entered into 
1 
RC10 Provide reassurance Give general reassurance to the smoker that his/her experiences are normal and time limited, and provide positive 
expectations of success based on experience with other smokers in the same situation 
1 
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Table 2. Evidence-based BCTs (identified in ≥ 2 effective RCTs) for specialist 
pregnancy behavioural support compared to BCTs previously identified as evidence-
based for generic individual behavioural support* and as associated with improved 4-
week quit outcomes.** 
BCT Evidence-based for 
Specialist pregnancy 
behavioural support 
Evidence-based for 
generic individual 
behavioural support* 
Associated with 
four week quit 
outcomes** 
BM4 Provide rewards contingent on successfully stopping smoking    
BM11 Measure CO    
BS2 Facilitate relapse prevention and coping    
BM1 Provide information on the consequences of smoking and 
smoking cessation 
  X 
BS1 Facilitate barrier identification and problem solving   X 
BS3 Facilitate action planning/ identify relapse triggers    X 
BS4 Facilitate goal setting   X 
RI1 Assess current and past smoking behaviour   X 
RI2 Assess current readiness and ability to quit   X 
RC5 Offer/Direct towards appropriate written materials   X 
A2 Advise on/facilitate use of social support  X  
A1 Advise on stop smoking medication X   
A5 Give options for additional and later support X   
RC6 Provide information on withdrawal symptoms X  X 
RI3 Asses past history of quit attempts X  X 
BM6 Prompt commitment from the client there and then X  X 
RC8 Elicit Client views X X  
BS7 Advise on changing routine X X  
A3 Ask about experiences of stop smoking medications that the 
Smoker is using 
X X  
BS10 Advise on conserving mental resources X X  
RC9 Summarise information/ confirm Client decisions X X  
RC10 Provide reassurance X X  
BM2 Boost motivation and self-efficacy X X  
*From Michie, Churchill & West 2010; ** From West, Walia, Michie et al. 2010
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Table 3. Prevalence of identified evidence-based BCTs in NHS SSSs treatment manuals (n=13) for smoking cessation behavioural support in pregnancy 
BCT SSS 1 SSS 2 SSS 3 SSS 4 SSS 5 SSS 6 SSS 7 SSS 8 SSS 9  SSS 10 SSS 11 SSS 12 SSS 13 
 
BM11 Measure CO 
 
             
RC5 Offer/ Direct towards appropriate written 
materials 
 
             
BM1 Provide information on the consequences 
of smoking and smoking cessation 
 
             
RI2 Assess current readiness and ability to quit 
 
             
BM4 Provide rewards contingent on successfully 
stopping smoking 
 
             
BS3 Facilitate action planning 
 
             
BS4 Facilitate goal setting 
 
             
A2 Advise on/facilitate use of social support 
 
             
BS2 Facilitate relapse prevention and coping 
 
             
RI1 Assess current and past smoking behaviour 
 
             
BS1 Facilitate barrier identification and problem 
solving 
 
             
Total 
 
6 7 2 8 4 10 6 10 6 11 8 11 5 
 
 
